KUALA LUMPUR, Malaysia, May 27, 2013 /PRNewswire/ --
MED8 SDN BHD, GMMI SDN BHD, SYED NASIR BIN SYED AGIL T/A PERNIAGAAN NASLINE, PARIAMAN JATI SDN BHD and MOHAMMAD HAIRUN B. AHMAD T/A HSQA TECH are permanently prohibited to make, import, use, sell, stock or offer for sale safety IV catheter products that infringe B. Braun's Malaysian patents MY-143155A and MY-141712. B. Braun has successfully defended these patents against a counter-claim for invalidation of Braun's said Malaysian patents by Med8 and the other Defendants and convinced the Malaysian IP High Court that the safety IV Catheters of Med8, namely Easy Port Safety, Easy-Pen Safety, Easy-Cath Safety and Easy-Cath Wing Safety which are admitted to be identical to those of Poly Medicure Ltd., Haryana, India, infringe the aforementioned B. Braun patents. The initial court order dates back to 10 Oct. 2012 B. Braun successfully defended an appeal of the judgement on 8 April 2013 and was awarded costs of MYR 550.000 (€ 137.000). The Suit numbers are D22(IP) - 23 - 2011 and D22(IP) - 53 - 2010, which were consolidated into one suit.
This is one of several patent infringement suits either decided or running against Poly Medicure Ltd. and their distributors. B. Braun will continue to take the necessary actions to provide the best possible innovation to the health care market, while protecting its patented products such as Introcan Safety(R), Vasofix(R) Safety and Introcan Safety(R)3 against illegal infringement.
SOURCE B. Braun Melsungen AG